Home » Poniard Cancer Drug Fails Pivotal Study
Poniard Cancer Drug Fails Pivotal Study
Poniard Pharmaceuticals’ cancer drug picoplatin failed to significantly prolong survival in patients with advanced small cell lung cancer, according
to results of a pivotal study.
TheStreet
TheStreet
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May